FindMyRecallSubscribe
Class I: serious health riskTerminated

QuVa Pharma PHENYLephrine 1 mg/10 mL Recall

PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0

QuVa Pharma, Inc. · Sugar Land, TX

Risk level
Class I
Reported by FDA
Jul 13, 2016
Recall ID
D-1066-2016
Check your lot numberHow we source this data

Summary

QuVa Pharma recalled PHENYLephrine 1 mg/10 mL starting Mar 30, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-1066-2016 on Jul 13, 2016. Reason: Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.

Product description

PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only, Healix Infusion Therapy Inc, 1075 W Park One Drive, Suite 200, Sugar Land Texas 77478, Product Code: 75901-1205-35.

Lot numbers, UPCs & expiration codes

Lot #: 14312-0, Exp 4/15/2016

Where it was sold

CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1066-2016
Classification
Class I
Status
Terminated
Recall initiated
Mar 30, 2016
FDA report date
Jul 13, 2016
Quantity
20 cases
Recall type
Voluntary: Firm initiated
Recalling firm
QuVa Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-1066-2016, exactly as published.

Show all FDA fields
City
Sugar Land
State
TX
Status
Terminated
Country
United States
Event ID
73710
Address
1075 W Park One Dr Ste 100
Code information
Lot #: 14312-0, Exp 4/15/2016
Postal code
77478-2576
Report date
Jul 13, 2016
Product type
Drugs
Recall number
D-1066-2016
Classification
Class I
Recalling firm
QuVa Pharma, Inc.
Product quantity
20 cases
Termination date
Nov 29, 2016
Reason for recall
Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only, Healix Infusion Therapy Inc, 1075 W Park One Drive, Suite 200, Sugar Land Texas 77478, Product Code: 75901-1205-35.
Distribution pattern
CA
Recall initiation date
Mar 30, 2016
Initial firm notification
E-Mail
Center classification date
Jul 6, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1066-2016, published Jul 13, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls